Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD
Sponsor: Children's National Research Institute
This PHASE4 trial investigates Adult ADHD and is currently completed. Children's National Research Institute leads this study, which shows 9 recorded versions since 2004 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2024 — Jul 2024 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
-
Mar 2022 — Jan 2024 [monthly]
Unknown Status PHASE4
-
Jan 2021 — Mar 2022 [monthly]
Unknown Status PHASE4
▶ Show 4 earlier versions
-
Mar 2020 — Jan 2021 [monthly]
Unknown Status PHASE4
-
Sep 2019 — Mar 2020 [monthly]
Unknown Status PHASE4
-
Jun 2018 — Sep 2019 [monthly]
Unknown Status PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE4
First recorded
Dec 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's National Research Institute
- McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
- University of Maryland, College Park
For direct contact, visit the study record on ClinicalTrials.gov .